Keyphrases
BRCA mutation
50%
BRCA mutation Carriers
75%
BRCA2
50%
BRCA2 mutation
100%
Breast Cancer Mortality
25%
Breast Cancer Susceptibility Gene 1 (BRCA1)
100%
Cancer Incidence
25%
Cancer Mortality Rates
25%
Chemoprevention
25%
Contralateral Prophylactic Mastectomy
25%
Cost Discounting
25%
Cost-effective Strategy
25%
Cost-effectiveness
100%
Decision Analysis
25%
Discount Rate
25%
End Results Program
25%
Health Care Financing Administration
25%
Health Policy
25%
Incremental Cost-effectiveness Ratio
50%
Markov Modeling
25%
Mastectomy
50%
Medicaid
25%
Medicare
25%
Minimal Impact
25%
Model Accuracy
25%
Model Assumptions
25%
Monte Carlo Simulation
25%
Mortality Rate
25%
Mutation Carriers
25%
Old Age
25%
Oophorectomy
100%
Oral Contraceptives
25%
Ovarian Cancer Risk
25%
Penetrance
50%
Preference Rating
25%
Preventive Strategies
100%
Probabilistic Sensitivity Analysis
25%
Prophylactic Mastectomy
25%
Prophylactic Oophorectomy
25%
Prophylactic Surgery
25%
Quality Adjustment
50%
Salpingo-oophorectomy
25%
Sensitivity Analysis
25%
Surveillance Epidemiology
25%
Unaffected Carrier
25%
Medicine and Dentistry
Base
14%
BRCA Mutation
14%
BRCA1
100%
BRCA2
100%
Chemoprophylaxis
14%
Cost-Effectiveness Analysis
100%
Health Care Cost
42%
Health Care Financing
14%
Lifespan
14%
Malignant Neoplasm
14%
Mastectomy
42%
Medicare
14%
Monte Carlo Method
14%
Mortality Rate
28%
Oral Contraceptive
14%
Ovarian Cancer
14%
Ovariectomy
71%
Penetrance
28%
Preference
28%
Preventive Mastectomy
14%
Salpingooophorectomy
14%
Surveillance, Epidemiology, and End Results
14%
Tamoxifen
14%
Nursing and Health Professions
Base
20%
Chemoprophylaxis
20%
Cost Effectiveness Analysis
100%
Health Care Financing
20%
Health Care Policy
20%
Incremental Cost-Effectiveness Ratio
40%
Malignant Neoplasm
20%
Mastectomy
60%
Medicare
20%
Monte Carlo Method
20%
Mortality Rate
40%
Oral Contraceptive Agent
20%
Ovariectomy
100%
Ovary Cancer
20%
Penetrance
40%
Prophylactic Mastectomy
20%
Salpingooophorectomy
20%
Tamoxifen
20%